Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific antibodies. ABL Bio will receive an upfront payment and potential milestone ...

Murex, a global leader in enterprise-wide, cross-asset financial technology solutions used by sell-side and buy-side capital markets players, and Amazon Web Services, Inc. (AWS), an Amazon.com, Inc.

Cancer cells frequently express PD-L1 protein to evade immune attack. When PD-L1 on a tumor cell surface binds to PD-1 on a T cell, the T cell becomes inactivated and loses its ability to destroy the ...